drugset / Trial / NCT02263040

A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV

NCT02263040

Phase 1/2 Completed 170 enrolled Mount Sinai Hospital, Canada
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objective of this pilot study is to assess the immunogenicity and reactogenicity of Fluzone High Dose with Fluzone (standard adult dose) influenza vaccines in healthcare workers.

Timeline

Start
2014-10
Primary completion
2016-07
Completion
2016-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Influenza Virus Vaccine Vaccine 15 ug
Comparator Influenza Virus Vaccine Vaccine 60 ug

Indications